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Introduction: Kikuchi-Fujimoto disease, is usually a benign self-limiting disease which typically affects young females
under the age of 30 years and resolves without treatment within six months. However, when it occurs in the context
of connective tissue disease, particularly systemic lupus erythematosus (SLE), it is usually associated with a flare-up of
the patient’s symptoms, requiring treatment, and can lead to severe, potentially life-threatening sequelae.
Case description: Here, we report and compare two cases of unclassifiable connective tissue disease who developed
a Kikuchi-like lymphadenitis and sepsis-like clinical syndrome, including disseminated intravascular coagulation, which
proved rapidly fatal.
Discussion and evaluation: In our review of the literature, we found 55 cases of Kikuchi-Fujimoto disease occurring in
the context of definite connective tissue disease, 50 of which were associated with SLE. Of the 55 cases, 22 (40%) had
simultaneous onset with, 19 (35%) predated the onset of and 14 (25%) developed after the associated connective tissue
disease. Life-threatening autoimmune sequelae were reported in 8 cases, 2 of which were fatal. The aetiology of the
association remains unknown.
Conclusion: Kikuchi-Fujimoto disease is a histopathological diagnosis, and although the classical form appears to
represent a distinct entity, it is unclear whether it is always the same entity, regardless of the context in which it
occurs, or whether it represents a histological pattern with a variety of possible causes. In any case, the possibility
of auto-immune sequelae in patients with known autoimmune disease should always be considered if these patients
present with a sepsis-like clinical syndrome and no infective source is identified.
Keywords: Kikuchi-Fujimoto disease; Necrotising lymphadenitis; Connective tissue disease; Systemic lupus
erythematosus; LymphadenopathyIntroduction
Kikuchi-Fujimoto disease, also known as histiocytic
necrotising lymphadenitis, is a benign self-limiting dis-
ease which typically affects young females under the age
of 30 years and resolves without treatment within six
months. The disease was originally described in Japan in
1972 and is known to be more common in Asian popu-
lations. The aetiology is unknown, and knowledge about
the condition is derived mostly from case reports.
Although both viral and autoimmune aetiologies have
been proposed, there is no convincing evidence linking* Correspondence: rosslyn.rankin@nhs.net
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reproduction in any medium, provided the origKikuchi-Fujimoto disease to either of these aetiologies.
Although the disease course is normally self-limiting,
fatal cases are known to occur, with a reported fatality
rate of 2.1% (Kucukardali et al. 2007; Chan et al. 1989).
An association between a Kikuchi-like lymphadenitis
and autoimmune disease, particularly systemic lupus
erythematosus (SLE), has been noted. The lymphadenitis
occurring in this context can produce a sepsis-like
clinical syndrome which is potentially life-threatening.
Here, we compare and contrast two cases of patients
with longstanding connective tissue disease which
proved hard to classify, both of whom developed a fatal
Kikuchi-like lymphadenitis.This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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This was a case of a 57 year old woman with a long history
of connective tissue disease. She suffered from Raynaud’s
phenomenon for 35 years, and, at the age of 29, a biopsy
of nodular lesions affecting the elbows, ankles and hands
revealed rheumatoid nodules/granuloma annulare. She
subsequently developed widespread inflammatory arth-
ritis. She also suffered from psoriasis, and psoriatic ar-
thropathy was the preferred diagnosis for a period of time.
However, she had an autoantibody profile which included
a positive ANF with a speckled pattern, positive anti-La
and positive RNP, and mixed connective tissue disease
was eventually considered to be the most likely diagnosis.
Rheumatoid factor was negative. She had multiple drug
allergies, including to numerous antibiotics, and declined
systemic therapy. Her arthritis was treated with steroid









Estimated GFR (ml/min/1.73 m2) 20
Lactate (mmol/l) NA
Bilirubin (μmol/l) 7
Alkaline Phosphatase (units/l) 101
ALT (units/l) 399
Albumin (g/l) 11
Calcium (mmol/l) 1.54 2.12 adjusted
Magnesium (mmol/l) 1.16
Phosphate (mmol/l) 3.97
C-reactive protein (mg/l) 72




White cell count (109/l) 22.8
Neutrophils (109/l) 17.7
Prothrombin time (seconds) Too prolonged to qu
Partial prothrombin time (seconds) Too prolonged to qu
Fibrinogen (g/l) 1.2
D-Dimer (ng/ml) 34761
*Although this is the normal range, eGFR is not accurate at near-normal levels of G
above 60.She was admitted to the Medical Unit with a few
days history of fever, right flank pain and mild urinary
frequency. She had been having recurrent urinary tract
infections over the previous three months and was di-
agnosed with pyelonephritis. She was treated with tei-
coplanin and gentamicin and her symptoms improved.
However, blood cultures were negative and a renal
ultrasound scan was normal. She was discharged home,
but was readmitted three days later with a recurrence
of her symptoms. On admission she had a fever of
38-40°C and an erythematous rash on her trunk, but
physical examination was otherwise unremarkable. Her
CRP increased from 17 on admission to 72 the following
morning. Her white cell count was not elevated and a
chest X-ray showed no obvious consolidation. Her antibi-
otics were restarted. Three days later, she rapidly became
breathless, hypotensive, poorly perfused and tachycardic.arameters of both cases following the onset of their



























FR and many laboratories, including ours, do not quantify the eGFR if it is
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haematological derangement including raised phosphate
and creatinine levels, low albumin, a neutrophilia and
thrombocytopaenia/disseminated intravascular coagula-
tion (DIC) (Table 1). A diagnosis of septic shock was
made. During transfer to intensive care, she suffered a
cardiac arrest and failed to respond to resuscitation
attempts.
Post mortem examination was unremarkable, and no in-
fective source was identified. Histology of lymph nodes
harvested from the neck bilaterally, peritonsillar area, tra-
cheobronchial region, axillae, groins and small bowel mes-
entery, as well as the spleen, showed similar features.
There were large areas of interfollicular necrotising in-
flammation with a prominent histiocytic population and
admixed lymphocytic debris, but no neutrophils (Figure 1).
Immunohistochemistry revealed that the interfollicular/
paracortical areas were populated predominantly by cyto-
toxic/CD8-positive T-cells. The cause of death was given
as mixed connective tissue disease-associated necrotising
lymphadenitis and splenitis.
Case 2
This 55 year old woman had a complex history of con-
nective tissue disease; features of Sjogren’s syndrome
and SLE were present and she also had small fibre neur-
opathy and asthma. She had positive anti-Ro and anti-La
antibodies. She had been suffering from sciatica and wasFigure 1 Histology of lymph nodes and spleen from Case 1. A-B: Lo
C-D: Low (x100) and high (x400) power views of spleen.electively admitted for a decompression laminectomy of
L4/L5 to alleviate her symptoms. She had an uneventful
recovery and was discharged home.
10 days later, following significant sun exposure, she
was re-admitted with pyrexia (40°C), dizziness, loss of
balance, decreased hearing, diarrhoea, vomiting and a
non-blanching rash over the upper arms and thighs. A
clinical diagnosis of sepsis was made, and she was started
on broad-spectrum antibiotics. No infective source was
found. Stool cultures showed no evidence of Clostridium
difficile and the blood and urine cultures were negative.
An MRI of the lumbosacral spine showed features most in
keeping with a surgical seroma. Despite treatment, her
condition deteriorated over the next three days and she
was admitted to ITU with lactic acidosis, haemodynamic
collapse, and thrombocytopenia/DIC. Despite organ sup-
port, she died three days after her admission.
Post mortem examination was unremarkable and no in-
fective source was identified. The cervical, carinal and
para-aortic lymph nodes showed paracortical necrotising
inflammation with a prominent histiocytic population
admixed with lymphocytes and some karryorrhectic
debris, but no neutrophils (Figure 2A and B). The lym-
phocytes were predominantly cytotoxic/CD8-positive
T-cells. The lymph nodes also showed vascular throm-
bosis (Figure 2C and D), and one of the para-aortic
lymph nodes was extensively infarcted. Focal areas of
haemophagocytosis were identified (Figure 3). Thew (x100) and high (x400) power views of peritonsillar lymph node.
Figure 2 Histology of lymph nodes from Case 2. A-B Low (x100) and high (x400) power views of para-aortic lymph node. C. High power (x400)
view of same lymph node showing medium vessel thrombosis. D. Low power (x100) view of same lymph node showing large vessel thrombosis.
Sharma and Rankin SpringerPlus  (2015) 4:167 Page 4 of 10cause of death was given as SLE-associated Kikuchi
disease.
Discussion
The etiology of Kikuchi-Fujimoto disease remains un-
clear. Suggested causative agents which have been iso-
lated from lymph nodes exhibiting the disease include
Ebstein-Barr virus, HIV, human T-cell leukaemia virus
type 1, human herpesvirus type 6 and 8, hepatitis B
virus, parvovirus B19, herpes simplex, varicella zoster,Figure 3 High power (x400) view of para-aortic lymph node
showing a focus of haemophagocytosis.cytomegalovirus, Toxoplasma gondii, Brucella, Yersinia
enterolitica and parainfluenza virus (Kucukardali et al.
2007; Bosch et al. 2004; Bosch and Guilabert 2006). It
has been proposed that these agents activate CD8-
positive T cells leading to T-cell proliferation and apop-
tosis mediated by the Fas and perforin pathways. Engulf-
ment of the apoptotic debris by macrophages would
then give rise to the typical histological features. How-
ever, there is no conclusive evidence that any of these
agents are the cause of Kikuchi-Fujimoto disease. In
many cases, no infectious agent is found (Kucukardali
et al. 2007; Bosch et al. 2004; Bosch and Guilabert 2006).
The other main proposed aetiology is autoimmune,
based on the observation that a Kikuchi-like lymphadenitis
occurs in the context of autoimmune disease, particularly
SLE. The pathogenesis of SLE is believed to be related to
defective processing of apoptotic debris, resulting in com-
ponents of the debris being mistakenly presented to the
immune system. Situations in which apoptosis is increased,
such as Kikuchi-Fujimoto disease, could conceivably accel-
erate the generation of autoantibodies and increase the
levels of autoantigens present, precipitating a flare-up of
the disease (Santana et al. 2005). It has been suggested that
the trigger may be an autoimmune response to an epithe-
lial antigen, such as those seen in cutaneous SLE reactions
(Gordon et al. 2009). Electron microscopy has shown that
the histiocytes, activated lymphocytes and endothelial cells
in the affected lymph nodes of Kikuchi-Fujimoto disease
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endothelial cells and lymphocytes of patients with SLE
(Imamura et al. 1982). The significance of this observation
is uncertain, although it hints at a common pathogenesis.
Some authors consider it to be supporting evidence for a
hyperimmune response of viral aetiology (Gionanlis et al.
2009). It has been suggested that Kikuchi-Fujimoto disease
lies on the same disease spectrum as SLE, representing a
milder form of the disease (Gionanlis et al. 2009). There is
one report of two twin sisters who were human-leucocyte
antigen-identical, each of whom developed Kikuchi-
Fujimoto disease 10 years apart. This observation hints
at the possibility of a genetic predisposition. However,
neither of the sisters developed SLE or any other auto-
immune sequelae (Amir et al. 2002).
Kikuchi-Fujimoto disease is a histopathological diag-
nosis and is probably under-recognised. It is cha-
racterised by focal cortical and paracortical necrosis with
marked karyorrhexis and an infiltrate of crescentic
histiocytes and plasmacytoid monocytes which lacks
neutrophils. The appearances of lupus lymphadenitis can
be similar. Additional features seen in lupus lymphaden-
itis include neutrophils, plasma cells and haematoxylin
bodies, but distinction between the two entities is not
always possible. Many authors recommend long-term
follow-up of patients with Kikuchi-Fujimoto disease to
watch for the development of SLE (Santana et al. 2005;
Bosch et al. 2004; Bosch and Guilabert 2006). In the
analysis of 244 reported cases of Kikuchi-Fujimoto dis-
ease by Kucukardali et al., 56 (23%) were associated
non-infectious inflammatory diseases of which 32 (13%)
were associated with SLE (Kucukardali et al. 2007).
In the two cases presented here, the presence of
Kikuchi-like lymphadenitis in the context of connective
tissue disease produced a sepsis-like clinical picture,
with thrombocytopenia and DIC, which proved fatal.
The differential diagnosis included true sepsis, which
was the working diagnosis in both cases, and this posed
a difficult therapeutic dilemma given that the true diag-
noses in these cases are extremely rare, whereas sepsis is
common. In our review of the literature, we found re-
ports of 8 cases of similar life-threatening autoimmune
sequelae, 2 of which were fatal, 1 of which eventually
resulted in a persistent vegetative state, and 5 of which
were successfully treated with pulse corticosteroids with
or without cyclophosphamide (Tables 2, 3 and 4). Com-
mencement of such therapy in these cases would have
required definitive exclusion of an infective cause, for
which there was not enough time due to the rapidity of
the clinical decline. Tables 1 and 5 compare the clinical,
biochemical and haematological features of the two
cases. Both had connective tissue disease which was
difficult to classify, although it was eventually felt that
case 2 probably had SLE. The autoantibody profiles weredifferent, but both were non-specific. In case 1, the
necrotising lymphadenitis also involved the spleen. This is
an extremely rare finding in Kikuchi lymphadenitis, and
was a feature of one of the two previously reported fatal
cases of SLE-associated Kikuchi lymphadenitis (Quintas-
Cardama et al. 2003).
Case 2 had a number of features which are more
closely associated with SLE. Firstly, there was a history
of sun exposure. In this context, it is noteworthy that
anti-Ro and anti-La antibodies, which were positive in
this patient, are particularly associated with photosensitivity
(Sontheimer et al. 1979). One model of the pathogenesis of
photosensitivity in SLE proposes that exposure of keratino-
cytes to ultraviolet light increases the surface expression of
Ro antigen. Anti-Ro antibodies would then bind these re-
ceptors and precipitate a cutaneous reaction which then
begets a systemic reaction (Furukawa et al. 1999). It is
tempting to speculate that such a mechanism may have
triggered the final illness in Case 2, but this cannot be
known for certain. This case showed vascular thrombosis
in the affected lymph nodes, a feature which is seen in SLE.
Case 2 also showed focal evidence of haemophagocy-
tosis in the lymph nodes. This was an interesting ob-
servation, but one whose significance is uncertain.
Haemophagocytic syndrome has been previously de-
scribed in cases of Kikuchi-Fujimoto disease occurring
in the context of SLE (Wano et al. 2000; Kampitak
2008; Leyral et al. 2005). However, there was no con-
clusive evidence for the presence of the haemophago-
cytic syndrome in this case.
In our review of the literature, we found 55 cases of
Kikuchi-Fujimoto disease occurring in the context of
definite connective tissue disease, 50 of which were asso-
ciated with SLE. Of the 55 cases, 22 (40%) had simultan-
eous onset with, 19 (35%) predated the onset of and 14
(25%) developed after the associated connective tissue
disease. The association was usually associated with a
flare-up of disease activity, the severity of which varied.
Life-threatening autoimmune sequelae, as discussed above,
were reported in 8 cases, 2 of which resulted in fatalities
(Tables 2, 3 and 4).
The appearance of autoantibodies was associated with
the onset of the connective tissue disease rather than the
lymphadenitis in all but 2 cases. Of the two cases in
which autoantibodies were linked to the onset of lymph-
adenitis, one developed further antibodies following the
onset of SLE (Bachi 2002; Zuo et al. 2012). There were
several reported cases of Kikuchi-Fujimoto disease occur-
ring in the context of skin manifestations, which provided
interesting but conflicting insights into the relationship
between the lymphadenitis and the appearance of auto-
antibodies (Prignano et al. 2012; Paradela et al. 2008;
Yilmaz et al. 2006; Mootsikapun et al. 2002; Silver
et al. 2004). On the one hand, two of these cases had
Table 2 Clinical characteristics of previously reported cases of Kikuchi-Fujimoto disease occurring simultaneously with
connective tissue disease









(Gionanlis et al. 2009)
23 year old
Female
SLE ANA, anti-dsDNA, Anti-Ro,
Anti-La, anti-RNP
Renal failure.TTP. Responded to
immunosuppression + rituximab.
USA
(Smith and Petri 2013)
27 year old
Female
SLE ANA, anti dsDNA,
anticardiolipin IgG and IgM,
anti-Smith, anti-Ro, anti-La.
Developed lupus nephritis. Condition stable.
Japan (Aota et al. 2009) 36 year old
Male
SLE ANA Lymphadenitis resolved with corticosteroid
therapy. Developed lupus nephritis. Condition
stable at 4 month follow up.
France
(Gallien et al. 2008)
47 year old
Male
SLE ANA, anti-dsDNA Lymphadenitis resolved with corticosteroid
therapy.
France
(Frikha et al. 2008)
14 year old
Female
SLE ANA, anti-RNP, anti-Ro Lymphadenitis resolved with corticosteroid
therapy.
France
(Frikha et al. 2008)
23 year old
Female
SLE ANA, anti-dsDNA, anti-Sm,
anti-RNP, anti-Ro, anti-La.
Lymphadenitis resolved with corticosteroid
therapy.
Germany
(Hoffmann et al. 1991)
37 year old
Male
SLE HHV-6 No life-threatening sequelae.
England
(Shusang et al. 2008)
20 year old
Female
SLE Had 3 year history
of autoimmune hepatitis
ANA (at onset of autoimmune
hepatitis) Anti-Ro, anticardiolipin
(at onset of SLE)
Lymphadenitis resolved with corticosteroid
therapy.
Turkey
(Yilmaz et al. 2006)
53 year old
Female
SLE ANA No life-threatening sequelae.
Singapore





ANA, anti-dsDNA No life-threatening sequelae.
USA (Eisner et al. 1996) Young male SLE ANA Concurrent lupus nephritis. Complete remission
with corticosteroid therapy and cyclophosphamide.
France
(Leyral et al. 2005)
26 year old
Female
SLE ANA, anti-dsDNA Haemophagocytic syndrome with EBV infection.
Complete remission with corticosteroids.
Romania





Anti-Sm Complete remission with corticosteroid therapy
Brazil
(Santana et al. 2005)
20 year old
Female
SLE ANA, anti-Ro, anticardiolipin Lymphadenitis resolved with corticosteroid
therapy.
Spain
(Jimenez Saenz et al. 2001)
30 year old
Female
SLE ANA, anti-dsDNA, anti-RNP,
anti-scl 70
Complete remission with corticosteroid therapy.
USA (Mahajan et al. 2007) 56 year old
Female
SLE ANA, anti-dsDNA Partial improvement with hydroxychloroquine,
followed by complete remission.
USA (Gordon et al. 2009) 33 year old
Male
SLE ANA, anti-Smith, anti-RNP,
anti-Ro.
Complete remission with corticosteroid therapy.
Germany
(Cramer et al. 2010)
33 year old
Male






SLE ANA Severe auto-immune-related clinical sequelae
and cardiogenic shock. Patient died despite pulse
corticosteroid and cyclophosphamide therapy.
Spain (Sopena et al. 2012) 27 year old
Female





SLE ANA Good response to hydroxychloroquine.
Thailand (Kampitak 2008) 50 year old
Male
SLE ANA Developed haemophagocytic syndrome and
severe hospital acquired pneumonia and septic
shock. Patient died.
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Table 3 Clinical characteristics of reported cases of Kikuchi-Fujimoto disease occurring after the onset of connective tissue disease
Connective tissue disease predating necrotising lymphadenitis
Country and reference Age and gender Connective tissue disease Autoantibodies Outcome
Canada (Silver et al. 2004) 43 year old Female Discoid lupus erythematosus for 10 years None Recovered without treatment
India (Londhey et al. 2010) 39 year old Female SLE for 2 years (not initially diagnosed) ANA and anti-dsDNA No life-threatening sequelae. Responded to corticosteroids
and hydroxychloroquine. Asymptomatic at 1 year follow-up.
Canada (Pace-Asciak et al. 2008) 35 year old Female SLE (duration not stated) NA Lymphadenitis resolved with conservative management.
France (Frikha et al. 2008) 30 year old Female Mixed connective tissue disease for 8 years ANA, anticardiolipin Lymphadenitis resolved with corticosteroid therapy.
Taiwan (Chen and Lan 1998) 4 cases All female
Ages 21–35 years old
SLE for 8 days to 2 years Ribosomal-P antibodies (1 case)
RNP (1 case) None (2 cases)
No life-threatening sequelae
France (Abraham et al. 2011) 35 year old Female Overlap syndrome for 12 years Antiphospholipid antibodies Lymphadenitis resolved with corticosteroid therapy.
Sabah (Bachi 2002) 27 year old Female SLE – systemic symptoms for 2 months ANA, anti-Ro, anti-La at onset
of lymphadenitis
Complete remission with corticosteroid therapy.
Japan (Wano et al. 2000) 37 year old Female SLE for 2 years NA Haemophagocytic syndrome. Complete remission with
corticosteroid pulse therapy.
India (Londhey et al. 2010) 39 year old Female Onset of connective tissue disease for
4 years. Lymphadenitis first appeared after
2 years. SLE diagnosis established later.
ANA, anti-dsDNA. Complete remission with corticosteroid therapy.
Spain (Sopena et al. 2012) 2 cases 22 and 32 years
old Both Female
Both SLE. Onset not stated. ANA only (1 case) ANA, anticardiolipin,
anti-Ro, RNP (1 case)
Good response to therapy
Italy (Ruaro et al. 2014) 19 year old Male SLE, onset 2–3 months prior to diagnosis
of Kikuchi lymphadenitis
ANA only Initial good response to therapy, single episode of relapse
2 years after initial onset, subsequently symptom free on











Table 4 Clinical characteristics of reported cases of Kikuchi-Fujimoto disease occurring before the onset of connective tissue disease
Necrotising lymphadenitis predating connective tissue disease
Country and reference Age, gender Connective tissue disease Autoantibodies Outcome
Saudi Arabia (el-Ramahi et al. 1994) 22 year old Female SLE after 5 months ANA, anti-Sm, anti-dsDNA, anti-Ro, anti-La. Lymphadenitis resolved with corticosteroid therapy.
Saudi Arabia (el-Ramahi et al. 1994) 34 year old Female SLE after several months ANA, anti dsDNA, anti-Sm Not stated.
Thailand (Sanpavat et al. 2006) 28 year old Female SLE after 44 weeks ANA, anti-dsDNA Lymphadenitis resolved with corticosteroid therapy.
Spain (Paradela et al. 2008) 17 year old Female SLE onset after 9 months ANA, anti-dsDNA No life-threatening sequelae.
Australia (Goldblatt et al. 2008) 22 year old Female SLE after 3 months ANA, anti-Ro, anti-Sm at onset of SLE. Complete remission with corticosteroid therapy.
Australia (Goldblatt et al. 2008) 39 year old Female SLE after 14 months ANA, anti-dsDNA, anti-Ro, anti-Sm,
anticardiolipin.
Complete remission with immunosuppression.
Australia (Goldblatt et al. 2008) 31 year old Female SLE after 6 months ANA, anti-dsDNA, anti-Ro at onset of SLE Treated with corticosteroids, azathioprine and
hydroxychloroquine. 2 years later, developed
meningoencephalitis leading to a persistent
neuro-vegetative state.
Australia (Goldblatt et al. 2008) 14 year old Female SLE after a few days Anti-dsDNA at onset of SLE. Complex clinical course with lupus nephritis.
Eventual remission with B-cell depletion therapy.
Spain (Alijotas-Reig et al. 2008) 31 year old Female SLE after years. Lymphadenitis
was pregnancy-associated and
did not recur at onset of SLE.
ANA, anti-RNP, borderline anti-dsDNA
at onset of SLE.
Persisting arthralgias and asthenia.
Japan (Ogata et al. 2010) 7 year old Male Mixed connective tissue
disease after 2 months
Weak anti-Ro, anti-La, anti-Sm, antiphospholipid
and anti-RNP at onset of connective tissue disease
Complete remission with corticosteroid therapy.
Japan (Ogata et al. 2010) 6 year old Female SLE after 2 years ANA, anti-dsDNA, anti-Sm, anti-RNP at onset of SLE. Complete remission with corticosteroid and
cyclophosphamide pulse therapy.
Spain (Sopena et al. 2012) 4 cases 27–32 years
old All Female
Sjogren syndrome (2 cases)
SLE (1 case) SLE-like (1 case)
ANA, anti-Ro (Sjogren cases) ANA only (SLE-like case) 1 case had a near-fatal clinical course, treated
with intravenous immunoglobulins. 2 of the
remaining cases had relapses of lymphadenitis.
USA (Zuo et al. 2012) 23 year old Female SLE after three months ANA and rheumatoid factor at onset of
lymphadenitis ANA, anti-Ro, anti-La, anti-dsDNA,
anti-Smith, anti-RNP at onset of SLE
Not stated.
India (Patra and Bhattacharya 2013) 30 year old Female SLE after 2 years ANA, anti-dsDNA at onset of SLE Complete remission with immunosuppression.
Italy (Di Lernia et al. 2013) 42 year old Female Cutanerous lupus after
two months
Anti-Ro, ENA at onset of cutaneous lupus Complete remission with prednisolone
and hydroxychloroquine.











Table 5 Comparison of the main clinical and pathological features of the two cases (DIC = disseminated intravascular
coagulation; SLE = systemic lupus erythematosus)
Case 1 Case 2
Age and Gender 57 year old female. 55 year old female.
Past Medical History Mixed connective tissue disease - including arthritis,
Raynaud’s phenomenon and rheumatoid nodules/granuloma
annulare. Psoriasis. Multiple drug allergies.
SLE/ Sjogren’s syndrome. Small fibre
neuropathy. Asthma.
Clinical presentation No sun exposure. Pyrexia (38-40°C), flank pain, urinary frequency,
erythematous rash on trunk. Deteriorated into sepsis-like clinical picture.
Sun exposure. Pyrexia (40°C), non-blanching
rash over upper arms and thighs, sepsis-like
clinical picture.
Autoantibodies ANA with speckled pattern, anti-La and RNP. Anti-Ro and Anti-La.
Thrombocytopenia/DIC Yes Yes
Acidosis Yes Yes
Lymph node histology Necrotising lymphadenitis. Necrotising lymphadenitis.
Blood vessel thrombosis No Yes
Spleen involvement Yes No
Sharma and Rankin SpringerPlus  (2015) 4:167 Page 9 of 10positive ANA antibodies, but a diagnosis of SLE was
excluded (Prignano et al. 2012; Yilmaz et al. 2006). On
the other hand, one was a case of discoid lupus who de-
veloped Kikuchi-Fujimoto disease without developing
autoantibodies (Silver et al. 2004), and another was a case
which went on to develop SLE, with auto-antibodies
appearing only at the onset of SLE (Paradela et al. 2008).
As an aside, the authors of this report made the observa-
tion that cases of cutaneous manifestations of Kikuchi-
Fujimoto disease which progressed to SLE were associated
with interface dermatitis, and suggested that this feature
may be a predictor of progression. In one case, the lymph-
adenitis preceded the appearance of cutaneous lupus, with
autoantibodies appearing only at the onset of cutaneous
lupus (Vassilakopoulos et al. 2010). Autoantibodies have
also rarely been reported to appear in the classical self-
limiting form of Kikuchi’s lymphadenitis, resolving when
the lymphadenitis resolves (Vassilakopoulos et al. 2010).
Finally, one intriguing report described a case of Kikuchi-
Fujimoto disease and systemic SLE-like symptoms without
any autoantibodies. The symptoms resolved spontaneously
within 3 months without treatment, and did not recur
(Mootsikapun et al. 2002). Overall, although Kikuchi-like
lymphadenitis can rarely be associated with the appearance
of autoantibodies, these cases would appear to be the ex-
ception rather than the rule. This observation would argue
against a straightforward autoimmune aetiology.
In conclusion, Kikuchi-Fujimoto disease occurring in
the context of connective tissue disease does not usually
take the benign self-limiting course which typifies the
classical form of the disease. It is usually associated with
a flare-up of the connective tissue disease requiring
treatment, and can lead to severe, potentially life-
threatening sequelae. The aetiology of this effect is un-
clear, but clinically it can mimic sepsis. In this context,
the possibility of auto-immune sequelae in patients withknown autoimmune disease should always be considered
if no infective source is identified. Although the classical
self-limiting form of Kikuchi-Fujimoto disease appears to
represent a distinct clinical and pathological disease, it is
unclear whether it is always the same entity, regardless of
the context in which it occurs, or whether it represents a
histological pattern with a variety of possible causes.
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